Gene expression profiling in neuronal cells identifies a different type of transcriptome modulated by NF-Y.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 12 2020
Historique:
received: 29 05 2020
accepted: 27 11 2020
entrez: 11 12 2020
pubmed: 12 12 2020
medline: 13 5 2021
Statut: epublish

Résumé

A heterotrimeric transcription factor NF-Y is crucial for cell-cycle progression in various types of cells. In contrast, studies using NF-YA knockout mice have unveiled its essential role in endoplasmic reticulum (ER) homeostasis in neuronal cells. However, whether NF-Y modulates a different transcriptome to mediate distinct cellular functions remains obscure. Here, we knocked down NF-Y in two types of neuronal cells, neuro2a neuroblastoma cells and mouse brain striatal cells, and performed gene expression profiling. We found that down-regulated genes preferentially contained NF-Y-binding motifs in their proximal promoters, and notably enriched genes related to ER functions rather than those for cell cycle. This contrasts with the profiling data of HeLa and embryonic stem cells in which distinct down-regulation of cell cycle-related genes was observed. Clustering analysis further identified several functional clusters where populations of the down-regulated genes were highly distinct. Further analyses using chromatin immunoprecipitation and RNA-seq data revealed that the transcriptomic difference was not correlated with DNA binding of NF-Y but with splicing of NF-YA. These data suggest that neuronal cells have a different type of transcriptome in which ER-related genes are dominantly modulated by NF-Y, and imply that NF-YA splicing alteration could be involved in this cell type-specific gene modulation.

Identifiants

pubmed: 33303918
doi: 10.1038/s41598-020-78682-8
pii: 10.1038/s41598-020-78682-8
pmc: PMC7728767
doi:

Substances chimiques

CCAAT-Binding Factor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21714

Références

Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Biochim Biophys Acta. 2012 Apr;1825(2):131-9
pubmed: 22138487
Nat Genet. 2011 Dec 18;44(1):94-100
pubmed: 22179133
J Biol Chem. 1992 May 5;267(13):8984-90
pubmed: 1577736
Neuroreport. 1999 Aug 20;10(12):2435-8
pubmed: 10574348
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Blood. 2012 Feb 9;119(6):1380-9
pubmed: 22072554
PLoS Genet. 2007 Aug;3(8):e145
pubmed: 17784790
BMC Bioinformatics. 2011 Jan 26;12:35
pubmed: 21269502
Nucleic Acids Res. 2012 Sep 1;40(17):e128
pubmed: 22610855
J Neurocytol. 1998 Jan;27(1):1-14
pubmed: 9530995
Cancer Res. 2003 Dec 1;63(23):8167-72
pubmed: 14678971
BMC Genomics. 2008 Oct 16;9:488
pubmed: 18925949
J Biol Chem. 2020 Jul 17;295(29):9768-9785
pubmed: 32499373
Biochim Biophys Acta Gene Regul Mech. 2017 May;1860(5):598-603
pubmed: 27815195
Mol Cell Biol. 2000 Sep;20(18):6755-67
pubmed: 10958673
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Mol Biol Cell. 2003 Jul;14(7):2706-15
pubmed: 12857858
FEBS J. 2016 Mar;283(6):1077-87
pubmed: 26756308
Stem Cells. 2012 Nov;30(11):2450-9
pubmed: 22969033
Nature. 2012 Sep 6;489(7414):101-8
pubmed: 22955620
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
EMBO J. 2008 Mar 19;27(6):827-39
pubmed: 18288205
Trends Biochem Sci. 1998 May;23(5):174-8
pubmed: 9612081
Sci Rep. 2020 May 6;10(1):7610
pubmed: 32376919
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11728-33
pubmed: 16081537
Blood. 2003 Oct 1;102(7):2420-7
pubmed: 12791656
Genome Res. 2013 Aug;23(8):1195-209
pubmed: 23595228
Nucleic Acids Res. 2011 Jul;39(13):5356-68
pubmed: 21415014
Nat Commun. 2014 Feb 25;5:3354
pubmed: 24566496
Sci Rep. 2016 Sep 30;6:34575
pubmed: 27687130
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Mol Metab. 2015 Feb 13;4(5):392-405
pubmed: 25973387
BMC Genomics. 2017 Mar 16;18(1):237
pubmed: 28302071
Cells. 2020 Mar 24;9(3):
pubmed: 32214056
J Neurosci. 2009 May 20;29(20):6607-15
pubmed: 19458231
Sci Rep. 2011;1:136
pubmed: 22355653
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Biol Chem. 2017 Dec 1;292(48):19590-19604
pubmed: 28972157
J Cell Biochem. 2008 Aug 1;104(5):1708-23
pubmed: 18348279
Cancer Cell. 2006 Sep;10(3):191-202
pubmed: 16959611
BMC Bioinformatics. 2010 May 11;11:237
pubmed: 20459804
Biochim Biophys Acta. 2016 Apr;1859(4):627-38
pubmed: 26921500
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Front Neurosci. 2018 Feb 20;12:91
pubmed: 29515361
Mol Cell. 2014 Sep 4;55(5):708-22
pubmed: 25132174

Auteurs

Tomoyuki Yamanaka (T)

Laboratory of Structural Neuropathology, Doshisha University Graduate School of Brain Science, 1-3 Tatara Miyakodani, Kyotanabe-shi, Kyoto, 610-0394, Japan. toyamana@mail.doshisha.ac.jp.
Laboratory for Molecular Mechanisms of Brain Development, RIKEN Center for Brain Science, Saitama, 351-0198, Japan. toyamana@mail.doshisha.ac.jp.
Department of Neuroscience for Neurodegenerative Disorders, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan. toyamana@mail.doshisha.ac.jp.
Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Saitama, 351-0198, Japan. toyamana@mail.doshisha.ac.jp.

Haruko Miyazaki (H)

Laboratory of Structural Neuropathology, Doshisha University Graduate School of Brain Science, 1-3 Tatara Miyakodani, Kyotanabe-shi, Kyoto, 610-0394, Japan.
Laboratory for Molecular Mechanisms of Brain Development, RIKEN Center for Brain Science, Saitama, 351-0198, Japan.
Department of Neuroscience for Neurodegenerative Disorders, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan.
Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Saitama, 351-0198, Japan.

Asako Tosaki (A)

Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Saitama, 351-0198, Japan.

Sankar N Maity (SN)

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Tomomi Shimogori (T)

Laboratory for Molecular Mechanisms of Brain Development, RIKEN Center for Brain Science, Saitama, 351-0198, Japan.

Nobutaka Hattori (N)

Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan.

Nobuyuki Nukina (N)

Laboratory of Structural Neuropathology, Doshisha University Graduate School of Brain Science, 1-3 Tatara Miyakodani, Kyotanabe-shi, Kyoto, 610-0394, Japan. nnukina@mail.doshisha.ac.jp.
Laboratory for Molecular Mechanisms of Brain Development, RIKEN Center for Brain Science, Saitama, 351-0198, Japan. nnukina@mail.doshisha.ac.jp.
Department of Neuroscience for Neurodegenerative Disorders, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan. nnukina@mail.doshisha.ac.jp.
Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Saitama, 351-0198, Japan. nnukina@mail.doshisha.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH